Viromed to patent gene linked with cardiovascular diseases.

Published: 2006-01-25 06:56:00

Updated: 2006-01-25 06:56:00

Viromed, a bio venture company specialized in gene therapy, announced on Jan. 20 that a patent of the therapeutic gene linked with the cardiovascular diseases was successfully registered in Singapore.

The company said that the mode of the gene therapy induces an angiogenesis by expressing two ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK